Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma

The identification of the mutations that drive lung cancer have furnished new targets for the treatment of non-small cell lung cancer (NSCLC) and led to the development of targeted therapies such as tyrosine kinase inhibitors that are used to combat the molecular changes promoting cancer progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhieb, Dhoha, Belguith, Imen, Capelli, Laura, Chiadini, Elisa, Canale, Matteo, Bravaccini, Sara, Yangui, Ilhem, Boudawara, Ons, Jlidi, Rachid, Boudawara, Tahya, Calistri, Daniele, Ammar Keskes, Leila, Ulivi, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627075/
https://www.ncbi.nlm.nih.gov/pubmed/31141932
http://dx.doi.org/10.3390/cells8060514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627075/
https://www.ncbi.nlm.nih.gov/pubmed/31141932
http://dx.doi.org/10.3390/cells8060514

Ejemplares similares